Dr. William Williams, CEO of BriaCell Therapeutics Corp., a company immuno-oncology focused biotechnology company developing a targeted and safe approach to the management of cancer joins eHealth Radio and the Cancer Information and Health News Channels.
Listen to host Eric Michaels & guest Dr. William Williams discuss the following:
Dr. William Williams is a seasoned biopharmaceutical executive with over 35 years of industry and academic expertise, including significant clinical management in multinational pharmaceutical companies. Dr. Williams served as VP of Exploratory Development at Incyte Corporation from 2005 - 2016. There he facilitated entry of over 20 compounds into the clinic, including ruxolitinib (Jakafi), baricitinib, and epacadostat.
Dr. Williams served as Head of Rheumatology Research at the University of Pennsylvania, ran a major research program in receptor biology, including developing bioactive peptides that mimicked granulocyte-macrophage colony-stimulating factor (GM-CSF), a known stimulant of the immune system. He collaborated with David B. Weiner, Ph.D., a well-known leader in immuno-oncology and vaccine research, in the development of DNA vaccines and was able to bring novel DNA vaccines into the clinic for the treatment of cutaneous T cell lymphoma.
Dr. Williams earned his BSc. in Chemistry and Biotechnology from Massachusetts Institute of Technology and Medical Doctorate from Tufts University School of Medicine. Following his residency at the Boston VA Medical Center, Dr. Williams completed fellowship training in Rheumatology and Cellular Immunology at the University of Missouri. He then joined the molecular immunology laboratory of Mark I. Greene, MD, PhD, FRCP, at the University of Pennsylvania, developed novel methods of bioactive peptide design, and collaborated in the study of the activation of the p185/Human epidermal growth factor receptor 2 (HER2) receptor. HER-2 is a protein which is known to promote the growth of cancer cells. Dr. Williams is the named author at over 130 peer reviewed publications, over 15 patents and numerous Investigational New Drugs (INDs) and NDAs.
Website: www.briacell.com
Taking Control of Germs in the Palm of Your Hand with UVCeed
Dr. Martin M. Grajower, discusses innovations to help both physicians and patients fight the silent epidemic of fatty liver disease
The Power of Success: How to Cheerlead Instead of Compete and Win More
The First Guide to Teach Young Adults the Science Behind COVID-19
The universal need for adequate resources and services in suicide prevention
Health Leadership in Changing Times
New health beverage will give you that extra push!
What You Need to Know About Breast Implants and Breast Implant Disease
The Brain Game Changer
Former Hernia Surgeon, Dr. Freedman, turned patient advocate shares advice for avoiding mesh and no mesh misconceptions
Top Hollywood Plastic Surgeon Tells All!
Educating Physicians and Patients on the Silent Epidemic of Fatty Liver Disease
Mobile Health: Creating Healthy Cultures
How Telehealth is Enhancing Patient Care and Health Outcomes
Thinking Nervous-System First with Garrett Salpeter
Dahlia Rizk of Buckle Me Baby Coats: Making Every Ride Safe for Your Child
The Future of Healthcare: LifeQ, the provider of biometrics and health information derived from wearable devices
Growth of Medical Travel and Fostering Healthcare Innovation in the Not-for-Profit Healthcare Sector
How to boost your immune system through your diet and balance the good bacteria in your gut
Céline Fournier, PhD, Chief Medical Officer, Echosens Discusses the Clinical Evidence and Future of Liver Screening Technology
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
URGENŤÁCI